Lieselotte Walle-Vande
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Comparative insights into the apoptosome, inflammasomes and PIDDosome.
Journal: Nature reviews. Immunology
Published: April 01, 2026
Pyrin inflammasome-driven erosive arthritis caused by unprenylated RHO GTPase signaling.
Journal: EMBO molecular medicine
Published: January 31, 2025
Author Correction: Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets.
Journal: Nature reviews. Drug discovery
Published: November 28, 2024
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency.
Journal: Life science alliance
Published: February 04, 2024
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets.
Journal: Nature reviews. Drug discovery
Published: October 06, 2023
Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.
Journal: Scientific reports
Published: September 07, 2023
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3.
Journal: Rheumatology (Oxford, England)
Published: December 04, 2022
Oxylipins and metabolites from pyroptotic cells act as promoters of tissue repair.
Journal: Nature
Published: November 19, 2022
Nonredundancy of IL-1α and IL-1β is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection.
Journal: Science advances
Published: March 02, 2022
GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis.
Journal: EMBO reports
Published: November 04, 2021
Snapshot of a Deadly Embrace: The Caspase-1-GSDMD Interface.
Journal: Immunity
Published: July 16, 2020
Last Updated: 09/26/2026